Facebook
X
LinkedIn
ForwardHematology & Medical Oncology Practice Updates and Board Review Online Course
Access to this online course is available from the date of purchase until the course expires on September 28, 2028. Credit must be claimed within that time period.
Registration is required to claim CME credit.
Course Director: Kebede H. Begna, M.D.
Co-Directors: Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
The Hematology & Medical Oncology Practice Updates and Board Review online course provides up-to-date, practical information and best practices that can be immediately applied to clinical practice. The high-yield content also helps prepare candidates for the American Board of Internal Medicine (ABIM) initial and Maintenance of Certification (MOC) examinations in hematology and medical oncology.
Target Audience
This course is designed for hematologists, oncologists, internal medicine physicians, NPs, PAs and other internists with interest in hematology and medical oncology. Others that may find this course beneficial include physicians needing MOC and those preparing for certification or recertification in hematology and medical oncology.
Learning Objectives
- Choose appropriate molecular tests like next generation sequencing for cancer diagnosis
- Integrate into practice the most current treatment options like immuno- or targeted therapy for cancers
- Utilize evidence-based practice to manage patients with bleeding and/or clotting disorders
- Manage and mitigate important acute and long-term toxicities to treatment
Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 373.02 KB |
Course summary
- 27.25 AMA PRA Category 1 Credit™
- 27.25 Attendance
Hematology & Medical Oncology Practice Updates and Board Review Online Course
September 29, 2026 - September 28, 2028
Duration | Lecture Title | Speaker(s) |
0:17:04 | Myeloproliferative Neoplasms | Naseema Gangat, M.B.B.S. |
0:19:09 | Mast Cell and Eosinophilic Neoplasms | Animesh Pardanani, M.B.B.S., M.D. |
0:35:04 | Bone Marrow Failure Syndromes | Abhishek A. Mangaonkar, M.B.B.S. |
0:22:00 | Chronic Myeloid Leukemia: Contemporary Management and Board Review | Talha Badar, M.B.B.S., M.D. |
0:31:35 | AML in 2026 | James M. Foran, M.D. |
0:32:05 | Acute Lymphoblastic Leukemia Lymphoma | Kebede H. Begna, M.D. |
0:28:57 | Transplantation for Hematologic Disorders Including GVHD | William J. Hogan, M.B., B.Ch. |
0:25:52 | Platelet Disorders | Meera Sridharan, M.D., Ph.D. |
0:25:33 | Coagulation Factor Disorders: Molecular Basis, Inhe | Rajiv K. Pruthi, M.B.B.S. |
0:26:20 | Acquired Thrombocytopenia-ITP HLH and Porphyria | Alexandra P. Wolanskyj-Spinner, M.D. |
0:27:19 | Sickle Cell, Thalassemia, and Other Hemoglobinopathies | Marwan E. Shaikh, M.D. |
0:19:37 | Nutritional Anemias and Iron Disorders | Ronald S. Go, M.D. |
0:27:09 | Immune Hemolytic Anemia and Paroxysmal Nocturnal Hemoglobinuria | Surbhi Shah, M.B.B.S. |
0:19:44 | MGUS & Smoldering Myeloma | Rahma Warsame, M.D. |
0:15:14 | Waldenström's Macroglobulinemia | Morie A. Gertz, M.D. |
0:19:38 | Amyloidosis | Angela Dispenzieri, M.D. |
0:21:20 | Newly Diagnosed Myeloma | Shaji Kumar, M.D. |
0:22:46 | Relapsed and/or Refractory Multiple Myeloma | Wilson I. Gonsalves, M.D. |
0:20:13 | Plasma Cell Disorders | Sikander Ailawadhi, M.D. |
0:22:54 | Hodgkin Lymphoma | Gita Thanarajasingam, M.D. |
0:21:36 | T-cell Lymphomas | Stephen M. Ansell, M.D., Ph.D. |
0:21:53 | Chronic Lymphocytic Leukemia (CLL) | Lindsey E. Roeker, M.D. |
0:20:17 | Follicular Lymphoma | Thomas E. Witzig, M.D. |
0:20:24 | Mantle Cell Lymphoma | Javier L. Munoz, M.D., M.B.A. |
0:17:26 | Other Indolent Non- Hodgkin Lymphomas | Thomas M. Habermann, M.D. |
0:31:28 | Cancer of the Cervix, Uterus and Other Less Common GYN Cancers | Andrea E. Wahner Hendrickson, M.D. |
0:31:21 | Updates in Endocrine Malignancies | Mabel Ryder, M.D. |
0:25:31 | Genomics for Hematologists and Medical Oncologists | Karthik V. Giridhar, M.D. |
0:25:09 | Hereditary Cancer Syndromes | Jewel J. Samadder, M.D. |
0:25:09 | Transfusion Medicine | Justin E. Juskewitch, M.D., Ph.D. |
0:22:20 | Management of Thrombosis in Cancer | Robert D McBane, M.D. |
0:25:10 | Palliative Care and Symptom Management | Deirdre R. Pachman, M.D. |
0:18:32 | Assessing & Managing Complications of Therapy | Elizabeth J. Cathcart-Rake, M.D. |
0:33:23 | Evolving Role of Systemic Therapy in Early-Stage NSCLC | Vamsi Velcheti, M.D. |
0:48:01 | Advanced Stage NSCLC (With and Without Actionable Mutations) | Rami Manochakian, M.D. |
0:18:52 | Small Cell Lung Cancer | Vinicius Ernani, M.D. |
0:27:36 | Other Thoracic Malignancies | Konstantinos Leventakos, M.D., Ph.D. |
0:24:25 | Neuro-Oncology | Wendy J. Sherman, M.D. |
0:24:38 | Head and Neck Cancer Updates | Ashish V. Chintakuntlawar, M.B.B.S., Ph.D. |
0:21:03 | Sarcoma | Brittany L. Siontis, M.D. |
0:31:21 | Bladder Cancer Update | Parminder Singh, M.D. |
0:27:46 | Updates in Kidney Cancer Treatment... RCC in 2026 | Yousef Zakharia, M.D. |
0:21:16 | Germ Cell Cancers | Adam M. Kase, M.D. |
0:29:50 | Prostate Cancer | Dan S. Childs, M.D. |
0:22:30 | Updates in Breast Cancer | Kimberly S. Corbin, M.D. |
0:31:49 | Systemic Therapy for ER+HER2- Breast Cancer | Matthew P. Goetz, M.D. |
0:31:28 | Systemic Therapy for TNBC | Dame Idossa, M.D. |
0:30:03 | Systemic Therapy for HER2-Positive Breast Cancer: Curative and Palliative | Saranya Chumsri, M.D. |
0:34:08 | GI Cancer: Management of Early-Stage Colon and Rectal Cancers | Katrina S. Pedersen, M.D. |
0:35:14 | Advanced Colorectal Cancer (CRC) | Tanios S. Bekaii-Saab, M.D. |
0:31:15 | Upper GI and “Other” GI Cancers | Jason S. Starr, D.O. |
0:32:46 | Management of Hepatobiliary Cancers | Mitesh J. Borad, M.D. |
0:41:01 | Management of Pancreatic Cancer | Hani M. Babiker, M.D. |
27:23:14 Content Hours | ||
27.25 Credit Hours | ||
Course Director:
Kebede H. Begna, M.D.
Co-Directors:
Tanios S. Bekaii-Saab, M.D.
Naseema Gangat, M.B.B.S.
Wilson I. Gonsalves, M.D.
Thor R. Halfdanarson, M.D.
Rami Manochakian, M.D.
Sameer A. Parikh, M.B.B.S.
Kathryn J. Ruddy, M.D
Faculty:
Abhishek A. Mangaokar, M.B.B.S.
Adam M. Kase, M.D.
Alexandra P. Wolanskyj-Spinner, M.D.
Andrea E. Wahner Hendrickson, M.D.
Angela Dispenzieri, M.D.
Animesh Pardanani, M.B.B.S., M.D.
Ashish V. Chintakuntlawar, M.B.B.S., Ph.D.
Brittany L. Siontis, M.D.
Dame Idossa, M.D.
Dan S. Childs, M.D.
Deirdre R. Pachman, M.D.
Elizabeth J. Cathcart-Rake, M.D.
Gita Thanarajasingam, M.D.
Hani M. Babiker, M.D.
James M. Foran, M.D.
Jason S. Starr, D.O.
Javier L. Munoz, M.D., M.B.A.
Justin E. Juskewitch, M.D., Ph.D.
Karthik V. Giridhar, M.D.
Kathryn J. Ruddy, M.D. Ruddy, M.D.
Katrina S. Pedersen, M.D.
Kebede H. Begna, M.D.
Kimberly S. Corbin, M.D.
Kostantions Leventakos, M.D., Ph.D.
Linsey E. Roecker, M.D.
Mabel Ryder, M.D.
Marwan E. Shaikh, M.D.
Matthew P. Goetz, M.D.
Meera Sridharan, M.D., Ph.D.
Mitesh J. Borad, M.D.
Morie A. Gertz, M.D.
Naseema Gangat, M.B.B.S.
Jewel J. Samadder, M.D.
Parminder Singh, M.D.
Rahma Warsame, M.D.
Rajiv K. K. Pruthi, M.B.B.S.
Rami Manochakian, M.D.
Robert D. McBane II, M.D.
Ronald S. Go, M.D.
Roxana S. Dronca, M.D.
Sameer A. Parikh, M.B.B.S.
Saranya Chumsri, M.D.
John J. Weroha, M.D., Ph.D.
Shaji Kumar, M.D.
Sikander Ailawadhi, M.D.
Stephen M. Ansell, M.D., Ph.D.
Surbhi Shah, M.B.B.S.
Talha Badar, M.B.B.S., M.D.
Tanios S. Bekaii-Saab, M.D. Bekaii-Saab, M.D.
Thomas M. Habermann, M.D.
Thomas E. Witzing, M.D. Witzing, M.D.
Thor R. Halfdanarson M.D. Halfdanarson M.D.
Vamsi Velcheti, M.D.
Vinicius Ernani, M.D.
Wendy J. Sherman, M.D.
Wiliam J. Hogan, M.B., B.Ch.
Wilson I. Gonsalves, M.D.
Yousef Zakharia, M.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statements:
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 27.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 27.25 AMA PRA Category 1 Credit™
- 27.25 Attendance
Price
Prospective attendees, please note that the content for this online activity has been repurposed from the live education activity Hematology & Medical Oncology Practice Updates and Board Review 2026, 2/6/2026 – 2/10/2026. If you attended the live activity, you have already received credit for these educational sessions.
Access to this online course is available from the date of purchase until the course expires on September 28, 2028. Credit must be claimed within that time period.
Registration is required to claim CME credit.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.